Novanta Inc (NOVT)

Novanta's stock experienced a 33.97% decline from December 4, 2024, to December 2, 2025. The company announced its Q3 2025 financial results, reporting revenues of $247.8 million, a 1.4% increase from the same period in the prior year. The Board of Directors authorized an additional $200 million for the company's share repurchase program in September 2025. Insider trading activity included sales by the CEO and Thomas N Secor. Congressional members also traded NOVT stock. Institutional ownership saw shifts in Q3 2025, with some investors increasing and others decreasing their holdings. Novanta announced the pricing of a $550,000,000 Tangible Equity Units Offering and participated in investor conferences.

While Novanta's overall revenues are not highly seasonal, some individual product lines experience lower sales in the first quarter due to customers' annual capital budgeting cycles. The company observes strong demand for new products supporting physical AI applications, such as warehouse automation, precision robotics, humanoids, RFID, and EUV lithography. Healthcare markets are also thriving, driven by strong patient procedure growth and hospital spending, supporting high single-digit growth in Advanced Surgery. Medical consumables are a strategic focus, projected to account for approximately 15% of sales in 2025 with ongoing double-digit growth.

Novanta, Inc. is a global technology company providing components and subsystems to OEMs in medical, life science, bioprocessing, and advanced industrial markets. It operates in the Appliances, Electrical, and Electronics Manufacturing industry, with segments in Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. Key products include photonics-based solutions, medical-grade technologies, and robotics and automation solutions.

Novanta has a global presence with operations across North America, Europe, and Asia, encompassing over 25 locations worldwide and employing more than 700 engineers. Key locations include North America, Europe and Asia.

Novanta has maintained a strong brand reputation through innovation and strategic partnerships, focusing on proprietary technology solutions. The company actively invests in automation and robotics, demonstrated by its participation in industry events. A partnership with Identiv and the acquisition of Keonn Technologies, S.L. highlight its commitment to advanced solutions. The company reported strong operating performance in 2024, including gross margin expansion, adjusted EBITDA growth, and record cash flow generation, despite a challenging market. However, the company's stock price experienced a significant decline from December 2024 to December 2025, and there have been insider sales by the CEO and other executives in the past six months.

Novanta's ownership is predominantly institutional, with 86.72% of shares held by institutional investors. Major institutional shareholders include BlackRock, Inc., The Vanguard Group, Inc., Conestoga Capital Advisors, LLC, State Street Corp, and T. Rowe Price Group, Inc. Jec II Associates LLC is the largest individual shareholder, holding 13.32% of the company. Individual investors hold 0.88% of the shares.